Pradelli, L. (2014) “Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients”, Farmeconomia. Health economics and therapeutic pathways, 15(1S), pp. 5–14. doi: 10.7175/fe.v15i1s.973.